In recent years, studies have focused on the development of recombinant or synthetic renalase as a novel blood pressure-lowering drug (12), which may provide a new strategy for the treatment of hypertension and other cardiovascular diseases. This evidence concerns the gene RNLS and cardiovascular disorder.